See more : The New India Assurance Company Limited (NIACL.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Else Nutrition Holdings Inc. (BABYF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Else Nutrition Holdings Inc., a leading company in the Packaged Foods industry within the Consumer Defensive sector.
- INFAC Corporation (023810.KS) Income Statement Analysis – Financial Results
- SelfWealth Limited (SWF.AX) Income Statement Analysis – Financial Results
- Cisen Pharmaceutical Co., Ltd. (603367.SS) Income Statement Analysis – Financial Results
- Saha-Union Public Company Limited (SUC.BK) Income Statement Analysis – Financial Results
- Shandong Link Science and Technology Co.,Ltd. (001207.SZ) Income Statement Analysis – Financial Results
Else Nutrition Holdings Inc. (BABYF)
About Else Nutrition Holdings Inc.
Else Nutrition Holdings Inc. engages in the development, production, and sale of food and nutrition products for infants, toddlers, children, and adults in North America and Israel. It offers baby snacks; baby feeding accessories, such as feeding bottles and teats; plant-based baby formula products; toddler, children, and adult nutrition products; and complementary food products. The company also offers its products through online. Else Nutrition Holdings Inc. is headquartered in Tel Aviv-Yafo, Israel.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 9.36M | 8.53M | 4.69M | 1.48M | 554.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 9.45M | 7.22M | 3.94M | 984.00K | 303.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | -85.00K | 1.31M | 743.00K | 498.00K | 251.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit Ratio | -0.91% | 15.37% | 15.85% | 33.60% | 45.31% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 2.56M | 2.56M | 1.97M | 1.11M | 261.00K | 0.00 | 0.00 | 964.00 | 889.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 7.27M | 9.71M | 7.96M | 5.40M | 2.12M | 103.10K | 0.00 | 53.16K | 84.34K | 109.93K | 27.87K | 114.93K |
Selling & Marketing | 4.38M | 5.96M | 6.49M | 1.93M | 284.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 11.65M | 15.66M | 14.45M | 7.33M | 2.40M | 103.10K | 50.61K | 53.16K | 84.34K | 109.93K | 27.87K | 114.93K |
Other Expenses | -14.30M | 3.62M | 2.05M | 1.08M | 595.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | -85.00K | 21.85M | 18.46M | 9.52M | 3.26M | 108.60K | 50.61K | 54.13K | 85.23K | 109.93K | 27.87K | 114.93K |
Cost & Expenses | 25.61M | 29.06M | 22.41M | 10.50M | 3.56M | 108.60K | 50.61K | 54.13K | 85.23K | 109.93K | 27.87K | 114.93K |
Interest Income | 62.00K | 74.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 170.00 | 1.47K | 506.00 |
Interest Expense | 63.00K | 13.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 379.00K | 496.00K | 384.00K | 193.00K | 74.00K | 306.86K | 52.52K | 22.82K | 0.00 | 0.00 | 265.61K | 0.00 |
EBITDA | -15.17M | -17.11M | -17.15M | -8.70M | -2.81M | 0.00 | -50.61K | -54.13K | -85.23K | -109.93K | 237.74K | -114.93K |
EBITDA Ratio | -162.02% | -269.26% | -713.42% | 422.60% | -101.81% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -16.25M | -23.46M | -33.82M | 6.07M | -638.00K | -109.35K | -50.61K | -54.13K | -85.23K | -109.93K | -27.87K | -114.93K |
Operating Income Ratio | -173.58% | -275.08% | -721.61% | 409.58% | -115.16% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | 640.00K | 1.84M | 15.29M | -24.10M | -2.37M | 1.51K | 0.00 | 0.00 | 0.00 | 170.00 | -264.13K | 506.00 |
Income Before Tax | -15.61M | -17.61M | -1.62M | -24.10M | -5.38M | -107.84K | -50.61K | -54.13K | -85.23K | -109.76K | -292.00K | -114.42K |
Income Before Tax Ratio | -166.75% | -206.57% | -34.52% | -1,626.45% | -970.76% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | -5.84M | -16.10M | 15.09M | 2.37M | -307.61K | -51.76K | -22.81K | 0.00 | 0.00 | -1.47K | 0.00 |
Net Income | -15.61M | -11.77M | 14.48M | -39.19M | -7.75M | -107.84K | -50.61K | -54.13K | -85.23K | -109.76K | -292.00K | -114.42K |
Net Income Ratio | -166.75% | -138.06% | 309.02% | -2,644.47% | -1,398.56% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | -0.13 | -0.11 | 0.15 | -0.49 | -0.15 | -0.10 | -0.05 | -0.05 | -0.19 | -0.37 | -0.99 | -2.00 |
EPS Diluted | -0.12 | -0.11 | 0.14 | -0.48 | -0.15 | -0.10 | -0.05 | -0.05 | -0.19 | -0.37 | -0.99 | -2.00 |
Weighted Avg Shares Out | 116.78M | 108.68M | 97.46M | 80.35M | 50.40M | 1.05M | 1.04M | 1.04M | 439.32K | 294.00K | 294.00K | 57.28K |
Weighted Avg Shares Out (Dil) | 129.78M | 108.68M | 100.52M | 81.37M | 50.40M | 1.05M | 1.04M | 1.04M | 439.32K | 294.00K | 294.00K | 57.28K |
Else Nutrition Holdings Inc. (BABYF) Q3 2022 Earnings Call Transcript
Else Nutrition: Product Branding And Global Expansion Should Lead To Stock Price Appreciation
Else Nutrition Holdings Inc. (BABYF) CEO Hamutal Yitzhak on Q2 2022 Results - Earnings Call Transcript
Else Nutrition to Webcast Live at VirtualInvestorConferences.com June 23rd
Else Nutrition Holdings Inc. (BABYF) CEO Hamutal Yitzhak on Q1 2022 Results - Earnings Call Transcript
Else Nutrition expands product offerings at Big Y supermarket stores
Else Nutrition reports a 219% increase in fiscal year 2021 revenues as sales boom
Else Nutrition to launch its Toddler Omega drink on Amazon.com and Elsenutrition.com
Else Nutrition concludes successful preclinical study on plant-based infant formula
Else Nutrition says former American Academy of Pediatrics chair Dr Susan Baker to join its scientific advisory board
Source: https://incomestatements.info
Category: Stock Reports